Results 111 to 120 of about 748,173 (287)

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

Symptoms of Depression, Anxiety, and Posttraumatic Stress among Patients with Cardiac Pacemakers. [PDF]

open access: yesInt J Environ Res Public Health, 2022
Bürker BS, Hardersen RI, Lappegård KT.
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García   +17 more
wiley   +1 more source

Effectiveness of an educational program on coping, self-efficacy and health-related quality of life of patients with permanent pacemaker implantation: A quasi-experimental study

open access: yesInternational Journal of Africa Nursing Sciences
Patients undertaking long-lasting implantable pacemakers are challenged with numerous mental and psychosocial problems. Educating cardiac patients implanting pacemaker with important items regarding self-care management may stop healthcare problems ...
Noha Mohammed Ibrahim   +7 more
doaj   +1 more source

[How to: Basics of programming cardiac pacemakers]. [PDF]

open access: yesHerzschrittmacherther Elektrophysiol, 2022
Johnson V, Israel C, Schmitt J.
europepmc   +1 more source

Do mobile phones cause dysfunctions of cardiac pacemakers? [PDF]

open access: yes, 2006
Artykuł prezentuje problematykę badań stymulatorów serca eksponowanych na sztucznie generowane pole elektromagnetyczne przez systemy telefonii komórkowej.
Krawczyk, A.   +2 more
core  

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Interference by Modern Smartphones and Accessories with Cardiac Pacemakers and Defibrillators. [PDF]

open access: yesCurr Cardiol Rep, 2022
Nadeem F   +5 more
europepmc   +1 more source

Maternal and perinatal outcomes of pregnant women with echocardiographically high probability of pulmonary arterial hypertension

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to describe maternal and perinatal outcomes among pregnant women with echocardiographically high probability of pulmonary arterial hypertension (PAH) managed at a quaternary center and to compare outcomes between women with and without cardiac complications (CC).
Laura Belmont‐Rojo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy